Sharpe AH - Search Results

1

TCR-sequencing in cancer and autoimmunity: barcodes and beyond.

Pauken KE, Lagattuta KA, Lu BY, Lucca LE, Daud AI, Hafler DA, Kluger HM, Raychaudhuri S, Sharpe AH. Pauken KE, et al. Among authors: sharpe ah. Trends Immunol. 2022 Mar;43(3):180-194. doi: 10.1016/j.it.2022.01.002. Epub 2022 Jan 25. Trends Immunol. 2022. PMID: 35090787 Free PMC article. Review.

2

B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.

Greenfield EA, Howard E, Paradis T, Nguyen K, Benazzo F, McLean P, Höllsberg P, Davis G, Hafler DA, Sharpe AH, Freeman GJ, Kuchroo VK. Greenfield EA, et al. Among authors: sharpe ah. J Immunol. 1997 Mar 1;158(5):2025-34. J Immunol. 1997. PMID: 9036945

3

CTLA-4 and T cell activation.

Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH. Oosterwegel MA, et al. Among authors: sharpe ah. Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8. Curr Opin Immunol. 1999. PMID: 10375557 Review.

4

The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system.

Anderson DE, Sharpe AH, Hafler DA. Anderson DE, et al. Among authors: sharpe ah. Curr Opin Immunol. 1999 Dec;11(6):677-83. doi: 10.1016/s0952-7915(99)00036-9. Curr Opin Immunol. 1999. PMID: 10631554 Review.

5

PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. Latchman Y, et al. Among authors: sharpe ah. Nat Immunol. 2001 Mar;2(3):261-8. doi: 10.1038/85330. Nat Immunol. 2001. PMID: 11224527

6

Genetic background determines the requirement for B7 costimulation in induction of autoimmunity.

Jabs C, Greve B, Chang TT, Sobel RA, Sharpe AH, Kuchroo VK. Jabs C, et al. Among authors: sharpe ah. Eur J Immunol. 2002 Sep;32(9):2687-97. doi: 10.1002/1521-4141(200209)32:9<2687::AID-IMMU2687>3.0.CO;2-1. Eur J Immunol. 2002. PMID: 12207354 Free article.

7

The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens.

Lohr J, Knoechel B, Jiang S, Sharpe AH, Abbas AK. Lohr J, et al. Among authors: sharpe ah. Nat Immunol. 2003 Jul;4(7):664-9. doi: 10.1038/ni939. Epub 2003 May 25. Nat Immunol. 2003. PMID: 12766766

8

Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis.

Rodig N, Ryan T, Allen JA, Pang H, Grabie N, Chernova T, Greenfield EA, Liang SC, Sharpe AH, Lichtman AH, Freeman GJ. Rodig N, et al. Among authors: sharpe ah. Eur J Immunol. 2003 Nov;33(11):3117-26. doi: 10.1002/eji.200324270. Eur J Immunol. 2003. PMID: 14579280 Free article.

9

An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.

Vijayakrishnan L, Slavik JM, Illés Z, Greenwald RJ, Rainbow D, Greve B, Peterson LB, Hafler DA, Freeman GJ, Sharpe AH, Wicker LS, Kuchroo VK. Vijayakrishnan L, et al. Among authors: sharpe ah. Immunity. 2004 May;20(5):563-75. doi: 10.1016/s1074-7613(04)00110-4. Immunity. 2004. PMID: 15142525 Free article.

10

The B7/CD28 costimulatory family in autoimmunity.

Keir ME, Sharpe AH. Keir ME, et al. Among authors: sharpe ah. Immunol Rev. 2005 Apr;204:128-43. doi: 10.1111/j.0105-2896.2005.00242.x. Immunol Rev. 2005. PMID: 15790355 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

423 results

Search Page